Stockreport

Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025 [Yahoo! Finance]

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com
PDF targeted and immuno-oncology therapeutics, today announced it will present the final clinical results from Part B of the DeFianCe study ( NCT05480306 ), a Phase 2 study [Read more]